Roche
-
healthRoche’s Blood Test for Alzheimer’s Wins European Approval
Roche and Eli Lilly’s Elecsys pTau217 blood test, the first to rule out Alzheimer’s, receives CE Mark approval in Europe.
-
healthClosing Southeast Asia's Breast Cancer Care Gap
Southeast Asia faces a critical breast cancer crisis. Learn about the challenges and solutions to improve early detection and treatment across the region.
-
healthRoche Executive Discusses Future of MS Care
Hideki Garren shares insights on evolving multiple sclerosis treatment approaches.
-
techRoche Deploys 3,500 NVIDIA GPUs to Accelerate Global Drug Discovery
Pharmaceutical giant Roche integrates NVIDIA Blackwell architecture into R&D infrastructure to reduce development timelines and enhance diagnostic accuracy worldwide.
-
techRoche Deploys 3,500 Nvidia Blackwell GPUs for Drug Discovery
Roche accelerates pharmaceutical R&D with 3,500 Nvidia Blackwell GPUs, targeting obesity drugs and challenging Eli Lilly's market dominance.
-
techRoche Deploys 2,176 Nvidia GPUs to Accelerate AI-Driven Drug Development
Swiss pharma giant Roche now operates the industry’s largest Nvidia GPU footprint to speed up R&D using artificial intelligence.
-
healthRoche Invests $481M in South Korea Clinical Hub
Roche commits $481 million to establish a major clinical hub in South Korea, boosting global drug development and fostering biotech innovation.